These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31758532)

  • 1. Signal Transduction Via Co-stimulatory and Co-inhibitory Receptors.
    Ogawa S; Abe R
    Adv Exp Med Biol; 2019; 1189():85-133. PubMed ID: 31758532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CD28-B7 Family of Co-signaling Molecules.
    Nagai S; Azuma M
    Adv Exp Med Biol; 2019; 1189():25-51. PubMed ID: 31758530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lymphocyte coreceptors].
    Olive D
    Med Sci (Paris); 2006 Dec; 22(12):1069-74. PubMed ID: 17156728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of T cell co-stimulation and co-inhibition.
    Chen L; Flies DB
    Nat Rev Immunol; 2013 Apr; 13(4):227-42. PubMed ID: 23470321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of resting human primary T cells with chimeric receptors: costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain.
    Finney HM; Akbar AN; Lawson AD
    J Immunol; 2004 Jan; 172(1):104-13. PubMed ID: 14688315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell co-stimulatory molecules other than CD28.
    Watts TH; DeBenedette MA
    Curr Opin Immunol; 1999 Jun; 11(3):286-93. PubMed ID: 10375549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B7-H7 (HHLA2) inhibits T-cell activation and proliferation in the presence of TCR and CD28 signaling.
    Rieder SA; Wang J; White N; Qadri A; Menard C; Stephens G; Karnell JL; Rudd CE; Kolbeck R
    Cell Mol Immunol; 2021 Jun; 18(6):1503-1511. PubMed ID: 32005952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Dynamics of Co-signal Molecules in T-Cell Activation.
    Saito T
    Adv Exp Med Biol; 2019; 1189():135-152. PubMed ID: 31758533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects.
    Kagoya Y; Tanaka S; Guo T; Anczurowski M; Wang CH; Saso K; Butler MO; Minden MD; Hirano N
    Nat Med; 2018 Mar; 24(3):352-359. PubMed ID: 29400710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?
    Croft M
    Nat Rev Immunol; 2003 Aug; 3(8):609-20. PubMed ID: 12974476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inherited immunodeficiencies associated with proximal and distal defects in T cell receptor signaling and co-signaling.
    Latour S
    Biomed J; 2022 Apr; 45(2):321-333. PubMed ID: 35091087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD28 of T lymphocytes associates with phosphatidylinositol 3-kinase.
    August A; Dupont B
    Int Immunol; 1994 May; 6(5):769-74. PubMed ID: 8080844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of TNF receptor type-2 (p75) as a costimulator for IL-2 induction and T cell survival: a functional link to CD28.
    Kim EY; Teh HS
    J Immunol; 2004 Oct; 173(7):4500-9. PubMed ID: 15383581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional expression of human CD28 in murine T cell hybridomas.
    Couez D; Pagès F; Ragueneau M; Nunès J; Klasen S; Mawas C; Truneh A; Olive D
    Mol Immunol; 1994 Jan; 31(1):47-57. PubMed ID: 8302298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD28 co-stimulatory regimes differ in their dependence on phosphatidylinositol 3-kinase: common co-signals induced by CD80 and CD86.
    Cefai D; Cai YC; Hu H; Rudd C
    Int Immunol; 1996 Oct; 8(10):1609-16. PubMed ID: 8921441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the strength of co-stimulation through the B7/CD28 pathway alter functional T cell responses to altered peptide ligands.
    Murtaza A; Kuchroo VK; Freeman GJ
    Int Immunol; 1999 Mar; 11(3):407-16. PubMed ID: 10221652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.
    Zhang YQ; Joost van Neerven RJ; Van Gool SW; Coorevits L; de Boer M; Ceuppens JL
    Int Immunol; 1997 Aug; 9(8):1095-102. PubMed ID: 9263006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD28 ligation induces rapid tyrosine phosphorylation of the linker molecule LAT in the absence of Syk and ZAP-70 tyrosine phosphorylation.
    Tsuchida M; Manthei ER; Knechtle SJ; Hamawy MM
    Eur J Immunol; 1999 Jul; 29(7):2354-9. PubMed ID: 10427998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The insulin-like growth factor-I receptor is regulated by CD28 and protects activated T cells from apoptosis.
    Walsh PT; O'Connor R
    Eur J Immunol; 2000 Apr; 30(4):1010-8. PubMed ID: 10760788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BY55/CD160 acts as a co-receptor in TCR signal transduction of a human circulating cytotoxic effector T lymphocyte subset lacking CD28 expression.
    Nikolova M; Marie-Cardine A; Boumsell L; Bensussan A
    Int Immunol; 2002 May; 14(5):445-51. PubMed ID: 11978774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.